INGN
Inogen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.42
−0.55%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.1x
Market Cap
$143.84M
MomentumView details →
1D Return
−0.55%
YTD Return
−19.12%
RSI (14)
34.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.1x
Market Cap
$143.84M
RSI (14)
34.4
MomentumView details →
1D Return
−0.55%
YTD Return
−19.12%
SummaryUpdated Jun 1, 2026
Inogen, Inc. (NASDAQ:INGN) is a medical technology company founded in 2001 and headquartered in Goleta, California. The company went public in February 2014 and specializes in developing, manufacturing, and marketing portable oxygen concentrators and related respiratory medical devices. Inogen serves patients with chronic respiratory conditions who require supplemental oxygen therapy, operating primarily in the United States with expanding international presence. The company has evolved from a pure-play portable oxygen concentrator manufacturer to a broader respiratory care solutions provider, recently expanding its product portfolio through acquisitions and new product development.
Similar companies
Latest newsMore news →